Related Experiment Video

Updated: Aug 13, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Cell transplantation for the treatment of Parkinson's disease

T Subramanian1

  • 1Department of Neurology, Cleveland Clinic Foundation, OH 44195, USA.

Seminars in Neurology
|May 11, 2001
PubMed

Insights

Cell transplantation shows promise for Parkinson's disease (PD) treatment. Research explores alternative cell sources and strategies to improve transplant survival and reduce immune rejection for advanced PD.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Clinical Neurology

Background:

  • Cell transplantation is an experimental therapy for Parkinson's disease (PD) and other movement disorders.
  • Striatal transplantation of allogeneic fetal ventral mesencephalic (FVM) tissue has shown clinically meaningful improvements in parkinsonian signs and symptoms.
  • Ethical concerns, surgical variability, and late complications have limited the use of allogeneic FVM tissue.

Purpose of the Study:

  • To review recent advances in cell therapy for advanced Parkinson's disease.
  • To compare the clinical utility of emerging cell therapies for PD.
  • To discuss novel strategies for improving cell survival and immune tolerance in transplantation.

Main Methods:

  • Review of preclinical and clinical trial data on cell transplantation for PD.
  • Analysis of alternative cell sources, including porcine FVM and retinal pigment epithelial cells.
  • Evaluation of novel strategies aimed at enhancing cell survival and mitigating immune rejection.

Main Results:

  • Allogeneic FVM transplantation has demonstrated efficacy but faces limitations.
  • Alternative cell sources and novel strategies show promise in preclinical and early clinical trials.
  • Advances in cell survival and immune tolerance are crucial for successful transplantation.

Conclusions:

  • Emerging cell therapies offer potential for treating advanced Parkinson's disease.
  • Continued research into alternative cell sources and supportive strategies is essential.
  • Optimizing cell survival and immune compatibility will be key to clinical success.

More Related Videos

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury10:49

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...